Recent developments in the lawsuits for Testim and other testosterone products include an August 22 Case Management Conference in which the legal counsel for the plaintiffs and the defendants met to discuss the procedure for discovery, according to court documents. Among the defendants is Auxilium Pharmaceuticals, the maker of Testim testosterone therapy. Testim and other testosterone therapies have FDA approval only for patients who are documented to have a low level of natural testosterone and also suffer from associated health problems, according to the January 31, 2014 Drug Safety Communication. Other complaints can be misdiagnosed as hypogonadism; the only way to confirm hypoginadism is through a blood test. The Journal of the American Medical Institute published research showing that as many as 25% of men taking testosterone drugs such as Testim never had their testosterone levels tested.****